Scientists
Collaborators
Research Staff
Graduate Students
Research Assistants
Biography:
Catherine Gallagher , MD, is a neurologist and movement disorders specialist who is studying PET and MRI biomarkers in Parkinson’s disease. She is also experienced in the diagnosis of AD and non-Alzheimer dementias. She holds a career development award from the VA that supports her current research efforts.
Publications:
-
Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer’s disease
January 1, 2013
-
Low cerebral blood flow is associated with lower memory function in metabolic syndrome.
January 1, 2013
-
White matter microstructural integrity and executive function in Parkinson’s disease
December 1, 2012
-
Rate of 6-[18F]fluoro-L-dopa uptake decline in striatal subregions in Parkinson’s disease
March 26, 2011
-
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease
January 1, 2011
-
A within-subject comparison of 6-[18F]Fluoro-m-tyrosine and 6-[18F]Fluoro-L-dopa in Parkinson’s disease
January 1, 2011
-
NSAIDs may protect against age-related brain atrophy
September 3, 2010
-
Homocysteine, neural atrophy, and the effect of caloric restriction in rhesus monkeys
August 4, 2010
-
Low HDL cholesterol is associated with lower gray matter volume in cognitively healthy adults
July 15, 2010
-
Midlife predictors of Alzheimer's disease
December 29, 2009
